India to Australia: Metformin Export Trade Route

The India to Australia Metformin corridor is one of India's established pharmaceutical export routes, with 440 shipments documented worth a combined $12.4M USD. The route is dominated by BAFNA PHARMACEUTICALS LIMITED, which alone accounts for roughly 28% of all export value, reflecting the consolidated nature of India's metformin manufacturing sector.

Across 17 active suppliers, the average shipment value stands at $28.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with metformin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 24.7%, placing it at rank #17 among India's top metformin export destinations globally.

On the import side, key buyers of Indian metformin in Australia include ARROW PHARMACEUTICALS PTY LTD, ARROW PHARMACEUTICALS PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD and 33 others. ARROW PHARMACEUTICALS PTY LTD is the single largest importer with 70 shipments valued at $3.0M USD.

India's metformin exports to Australia are driven primarily by a handful of large-scale manufacturers. BAFNA PHARMACEUTICALS LIMITED with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BAFNA PHARMACEUTICALS LIMITED, ALKEM LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED — together account for 55% of total trade value on this route. The average shipment value of $28.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as metex xr metformin hydrochloride prolon and metex xr metformin hydrochloride prolonged release tablets 500 mg xr, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ARROW PHARMACEUTICALS PTY LTD is the largest importer with 70 shipments worth $3.0M USD — representing 25% of all metformin imports from India on this route. A total of 36 buyers are active on this corridor.